To investigate the prognostic implications of the NKX2‐5/LHX1/UHRF1 axis in ESCC patients, we constructed a comprehensive regulatory model incorporating NKX2‐5, LHX1, UHRF1, DNMT1, and DNMT3A. This evidence concerns the gene UHRF1 and esophageal squamous cell carcinoma.